insights_auto
Why is TMCI down 10,71%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,00 $
arrow_downward
-10,71%(-0,48) 1D
6 հոկ, 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,53 $
High
4,53 $
Low
3,98 $
Mkt. cap
254,91 մլն
Avg. vol.
235,91 հզր
Volume
652,02 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,53 $
High
4,53 $
Low
3,98 $
Mkt. cap
254,91 մլն
Avg. vol.
235,91 հզր
Volume
652,02 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
Business Wire
·
23 րոպե առաջ
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fox Business
·
27 րոպե առաջ
S&P 500, Nasdaq surge to record highs
The Motley Fool
·
19 րոպե առաջ
Is Now the Time to Cash Out of the S&P 500's Top 3 Stocks of 2026?
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc